Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Apr 2026 for NovaBridge Biosciences, €494k.
Filing timeline
BuySaleMark Arnold Hagler
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -43.4%Entry US$2.35 · Close 22 Oct 2026 US$1.33
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark Arnold Hagler: trading record in brief
One trade, one date: on 28 April 2026, Mark Arnold Hagler disclosed an open-market purchase of €494k in NovaBridge Biosciences. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Arnold Hagler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 230,000 shares@ US$2.510.24% mcap100.0% of flowOrdinary SharesSEC:0001193125-26-186924:0Canonical exit: 23 Jul 2026 (T+90)
1 of 1 declaration